tci Part B Insider - 2003 Issue 8

DRUG REIMBURSEMENT: CMS Invites Least Costly Alternative for Drugs

Medicare's new Single Drug Pricer doesn't mean that the Centers for Medicare & Medicaid Services has given up on the idea of using inherent reasonableness to cut drug payments, CMS says in a new program memo. The new memo, AB-03-047, also corrects Medicare prices for two drugs, retroactive to Jan. 1. Medicare will reimburse $76 per dose for J1563, injections of intravenous immune globulin, and $16.45 per dose for J1260, dolasetron mesylate. An earlier correction, issued Jan. 14, had reduced the rate for J1563 to $55 per dose. The Jan. 14 correction, issued in a "joint letter,"...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.